How do insurance companies determine whether a treatment or procedure is medically necessary?
The Arguments
WHAT THE INDUSTRY ARGUES
Insurance companies argue that medical necessity determinations protect patients from unnecessary or harmful treatments and help control healthcare costs. They employ clinical guidelines, evidence-based criteria, and review processes—sometimes involving licensed medical professionals—to evaluate whether a proposed treatment is appropriate for a patient’s specific diagnosis and condition. Insurers contend these standardized reviews ensure that healthcare spending is directed toward treatments proven to be effective.
WHAT CRITICS ARGUE
Critics argue that medical necessity decisions are often driven by cost containment rather than patient welfare, and that insurers may deny or delay care that treating physicians have recommended. They point out that the criteria used can be opaque, vary significantly between insurers, and may rely on rigid algorithms or outside reviewers unfamiliar with a patient’s full medical history. Some critics also raise concerns about the growing use of AI and outsourced clinical review processes, noting that autonomous technology and remote personnel may lack the nuanced judgment needed for complex medical decisions.
The Data
WHAT THE DATA SHOWS
Reporting on the healthcare outsourcing industry notes that the global healthcare outsourcing market exceeds $423 billion, with clinical review functions increasingly handled by overseas professionals and AI-assisted tools—raising questions about who ultimately makes these determinations and under what oversight.
The Bottom Line
BOTTOM LINE
Medical necessity determinations involve a mix of clinical guidelines, insurer policies, and review processes, but the criteria and decision-makers behind them remain a point of ongoing debate between insurers and patient advocates.